Sobi™ initiates disclosure of payments to the healthcare industry to increase transparency
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announced that the company has started implementing the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code to make all payments and transfers of value to healthcare professionals and organisations from 2015 publicly available, including sponsorships to attend meetings, speaker fees, consultancy and advisory boards. The information will be made available on Sobi´s corporate web site, starting 31 May 2016. The implementation of the EFPIA Disclosure Code is an important part of